Search by Drug Name or NDC

    NDC 00228-2890-06 Duloxetine 20 mg/1 Details

    Duloxetine 20 mg/1

    Duloxetine is a ORAL CAPSULE, DELAYED RELEASE PELLETS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is DULOXETINE HYDROCHLORIDE.

    Product Information

    NDC 00228-2890
    Product ID 0228-2890_30d458c8-d191-4e8a-a93a-986081db7e27
    Associated GPIs 58180025106720
    GCN Sequence Number 057891
    GCN Sequence Number Description duloxetine HCl CAPSULE DR 20 MG ORAL
    HIC3 H7C
    HIC3 Description SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS)
    GCN 23161
    HICL Sequence Number 026521
    HICL Sequence Number Description DULOXETINE HCL
    Brand/Generic Generic
    Proprietary Name Duloxetine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Duloxetine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, DELAYED RELEASE PELLETS
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name DULOXETINE HYDROCHLORIDE
    Labeler Name Actavis Pharma, Inc.
    Pharmaceutical Class Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090776
    Listing Certified Through 2024-12-31

    Package

    NDC 00228-2890-06 (00228289006)

    NDC Package Code 0228-2890-06
    Billing NDC 00228289006
    Package 60 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0228-2890-06)
    Marketing Start Date 2013-12-17
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.11888
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description DULOXETINE HCL DR 20 MG CAP
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis